A mutation affecting the latency-associated peptide of TGFβ1 in Camurati-Engelmann disease enhances osteoclast formation in vitro

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 7, 2003, Pages 3321-3326

  McGowan, Neil W A ^a,e   MacPherson, Heather ^a,f   Janssens, Katrien ^b   Van Hul, Wim ^b   Frith, Julie C ^a   Fraser, William D ^c   Ralston, Stuart H ^a   Helfrich, Miep H ^a,d  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; COLONY STIMULATING FACTOR 1; DEXAMETHASONE; LATENCY ASSOCIATED PEPTIDE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PREDNISOLONE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BONE DENSITY; BONE DISEASE; BONE DYSPLASIA; BONE MINERAL; CAMURATI ENGELMANN SYNDROME; CASE REPORT; CELL CULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMUR NECK; GENE MUTATION; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; PELVIS RADIOGRAPHY; PRIORITY JOURNAL; SPINE RADIOGRAPHY;

ADULT; AGED; ANTIBODIES; CAMURATI-ENGELMANN SYNDROME; CARRIER PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MEMBRANE GLYCOPROTEINS; OSTEOCLASTS; POINT MUTATION; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0038298240     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020564     Document Type: Article

References (23)

1. Janssens K, Gershoni-Baruch R, Guanabens N, Migone N, Ralston S, Bonduelle M, Lissens W, Van Maldergem L, Vanhoenacker F, Verbruggen L, Van Hul W 2000 Mutations in the gene encoding the latency-associated peptide of TGF-beta1 cause Camurati-Engelmann disease. Nat Genet 26:273-275
2. Kinoshita A, Saito T, Tomita H, Makita Y, Yoshida K, Ghadami M, Yamada K, Kondo S, Ikegawa S, Nishimura G, Fukushima Y, Nakagomi T, Saito H, Sugimoto T, Kamegaya M, Hisa K, Murray JC, Taniguchi N, Niikawa N, Yoshiura K 2000 Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease. Nat Genet 26:19-20
3. Centrella M, Horowitz MC, Wozney JM, McCarthy TL 1994 Transforming growth factor-beta gene family members and bone. Endocr Rev 15:27-39
4. Bonewald LF, Dallas SL 1994 Role of active and latent transforming growth factor beta in bone formation. J Cell Biochem 55:350-357
5. Sells Galvin RJ, Gatlin CL, Horn JW, Fuson TR 1999 TGF-beta enhances osteoclast differentiation in hematopoietic cell cultures stimulated with RANKL and M-CSF. Biochem Biophys Res Commun 265:233-239
6. Fuller K, Lean JM, Bayley KE, Wani MR, Chambers TJ 2000 A role for TGFbeta(1) in osteoclast differentiation and survival. J Cell Sci 113:2445-2453
7. Massey HM, Scopes J, Horton MA, Flanagan AM 2001 Transforming growth factor-beta1 (TGF-beta) stimulates the osteoclast-forming potential of peripheral blood hematopoietic precursors in a lymphocyte-rich microenvironment. Bone 28:577-582
8. McGowan NW, Walker EJ, MacPherson H, Ralston SH, Helfrich MH 2001 Cytokine-activated endothelium recruits osteoclast precursors. Endocrinology 142:1678-1681
9. Saito T, Kinoshita A, Yoshiura K, Makita Y, Wakui K, Honke K, Niikawa N, Taniguchi N 2001 Domain-specific mutations of a transforming growth factor (TGF)-beta 1 latency-associated peptide cause Camurati-Engelmann disease because of the formation of a constitutively active form of TGF-beta 1. J Biol Chem 276:11469-11472
10. Janssens K, ten Dijke P, Ralston SH, Van Hul W 2003 Transforming growth factor beta-1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein. J Biol Chem 278:7718-7724
11. Hernandez MV, Peris P, Guanabens N, Alvarez L, Monegal A, Pons F, Ponce A, Munoz-Gomez J 1997 Biochemical markers of bone turnover in Camurati-Engelmann disease: a report on four cases in one family. Calcif Tissue Int 61:48-51
12. Bonewald LF, Mundy GR 1990 Role of transforming growth factor-beta in bone remodeling. Clin Orthop 261-276
13. Quinn JM, Itoh K, Udagawa N, Hausler K, Yasuda H, Shima N, Mizuno A, Higashio K, Takahashi N, Suda T, Martin TJ, Gillespie MT 2001 Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. J Bone Miner Res 16:1787-1794
14. Yan T, Riggs BL, Boyle WJ, Khosla S 2001 Regulation of osteoclastogenesis and RANK expression by TGF-beta1. J Cell Biochem 83:320-325
15. Chenu C, Pfeilschifter J, Mundy GR, Roodman GD 1988 Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures. Proc Natl Acad Sci USA 85:5683-5687
16. Hattersley G, Chambers TJ 1991 Effects of transforming growth factor beta 1 on the regulation of osteoclastic development and function. J Bone Miner Res 6:165-172
17. Pfeilschifter J, Seyedin SM, Mundy GR 1988 Transforming growth factor beta inhibits bone resorption in fetal rat bone cultures. J Clin Invest 82:680-685
18. Weitzmann MN, Cenci S, Haug J, Brown C, Dipersio J, Pacifici R 2000 B lymphocytes inhibit human osteoclastogenesis by secretion of TGFbeta. J Cell Biochem 78:318-324
19. Takai H, Kanematsu M, Yano K, Tsuda E, Higashio K, Ikeda K, Watanabe K, Yamada Y 1998 Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. J Biol Chem 273:27091-27096
20. Murakami T, Yamamoto M, Ono K, Nishikawa M, Nagata N, Motoyoshi K, Akatsu T 1998 Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells. Biochem Biophys Res Commun 252:747-752
21. Thirunavukkarasu K, Miles RR, Halladay DL, Yang X, Galvin RJ, Chandrasekhar S, Martin TJ, Onyia JE 2001 Stimulation of osteoprotegerin (OPG) gene expression by transforming growth factor-beta (TGF-beta). Mapping of the OPG promoter region that mediates TGF-beta effects. J Biol Chem 276:36241-36250
22. Erlebacher A, Derynck R 1996 Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype. J Cell Biol 132:195-210
23. Erlebacher A, Filvaroff EH, Ye JQ, Derynck R 1998 Osteoblastic responses to TGF-beta during bone remodeling. Mol Biol Cell 9:1903-1918